Venous thromboembolism Risk of recurrence lower with rivaroxaban than aspirin

被引：0
|
作者：
Huynh, Karina
机构：
来源：
NATURE REVIEWS CARDIOLOGY | 2017年 / 14卷 / 05期
关键词：
D O I：
10.1038/nrcardio.2017.41
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [21] Anticoagulation quality and the risk of recurrence of venous thromboembolism
    Poli, Daniela
    Antonucci, Emilia
    Ciuti, Gabriele
    Abbate, Rosanna
    Prisco, Domenico
    THROMBOSIS AND HAEMOSTASIS, 2007, 98 (05) : 1148 - 1150
  • [22] THE SIGNIFICANCE OF HYPOFIBRINOLYSIS FOR THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM
    SCHULMAN, S
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1097 - 1097
  • [23] Characteristics and recurrence risk factors for venous thromboembolism
    Ruivard, M.
    Vaillant, H.
    Ouchchane, L.
    Dauphin, C.
    Marques-Verdier, A.
    Philippe, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1181 - 1181
  • [24] Risk of recurrence of unusual site venous thromboembolism
    Riva, N.
    Dentali, F.
    Donadini, M. P.
    Squizzato, A.
    Ageno, W.
    HAMOSTASEOLOGIE, 2013, 33 (03): : 225 - 231
  • [25] Family history for venous thromboembolism and the risk for recurrence
    Hron, G
    Eichinger, S
    Weltermann, A
    Minar, E
    Bialonczyk, C
    Hirschl, M
    Stain, M
    Gartner, V
    Kyrle, PA
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (01): : 50 - 53
  • [26] The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism
    Schulman, S
    Wiman, B
    Carlsson, A
    Gustafsson, C
    Grondahl, A
    Rhedin, AS
    Tornebohm, E
    Johansson, M
    Lockner, D
    Lindmarker, P
    Johnsson, H
    Nicol, P
    Kobosko, J
    Malmros, B
    Arcini, N
    Saaw, J
    Loogna, E
    Stig, R
    Viering, S
    Ljungberg, B
    Wilhelmsson, S
    Ohlsson, A
    Walter, H
    Malmqvist, K
    AlKhalili, F
    Leijd, B
    Petrescu, A
    Brohult, J
    Larfars, G
    Hulting, J
    Eklund, SG
    Svensson, E
    Dahlin, L
    Boberg, J
    Nordlander, S
    Marjanovics, B
    Linder, O
    Jonsson, KA
    Malm, C
    Hjorth, M
    Fagrell, B
    Kallner, M
    Granqvist, S
    Egberg, N
    Schulman, S
    Wadman, B
    Snyder, M
    THROMBOSIS AND HAEMOSTASIS, 1996, 75 (04) : 607 - 611
  • [27] Risk of recurrence and bleeding in patients with cancer-associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study
    Sogaard, Mette
    Nielsen, Peter Bronnum
    Skjoth, Flemming
    Kjaeldgaard, Jette Nordstrom
    Larsen, Torben Bjerregaard
    CANCER MEDICINE, 2019, 8 (03): : 1044 - 1053
  • [28] Aspirin Increases the Risk of Venous Thromboembolism in Surgical Patients
    Barmparas, Galinos
    Jain, Monica
    Mehrzadi, Devorah
    Melo, Nicolas
    Chung, Rex
    Bloom, Matthew
    Ley, Eric J.
    Margulies, Daniel R.
    AMERICAN SURGEON, 2014, 80 (10) : 920 - 925
  • [29] Rivaroxaban for the treatment of venous thromboembolism The SWISS Venous ThromboEmbolism Registry (SWIVTER)
    Kucher, Nils
    Aujesky, Drahomir
    Beer, Jurg H.
    Mazzolai, Lucia
    Baldi, Thomas
    Banyai, Martin
    Hayoz, Daniel
    Kaeslin, Thomas
    Korte, Wolfgang
    Escher, Robert
    Husmann, Marc
    Frauchiger, Beat
    Baumgartner, Iris
    Spirk, David
    THROMBOSIS AND HAEMOSTASIS, 2016, 116 (03) : 472 - 479
  • [30] Venous thromboembolism in trauma patients with lower limb cast immobilization, associated risk reduction and complication using rivaroxaban
    Ali, Imran A.
    Elbana, Husam
    Farhan, Munthir
    Qureshi, Idris Ford
    Mubashir, Ahmed
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (01) : 169 - 175
12345